iifl-logo

Amanta Healthcare Ltd Auditor Reports

141.88
(3.56%)
Sep 16, 2025|12:00:00 AM

Amanta Healthcare Ltd Share Price Auditors Report

To the Board of Directors of Amanta Healthcare Limited

Report on Restated Financial Information in connection with the Proposed Initial Public Offering Page 2 of 5

iii. the Guidance Note on Reports in Company Prospectuses (Revised 2019) issued by the Institute of Chartered Accountants of India (“ICAI”), as amended from time to time (the “Guidance Note”).

The said Restated Financial Information has been approved by the Board of Directors of the Company at their meeting held on July 17, 2025 for the purpose of inclusion in the Red Herring Prospectus (“RHP”) and the Prospectus (“Prospectus”) and signed by us under reference to this report.

Managements Responsibility for the Restated Financial Information

3. The preparation of the Restated Financial Information, for the purpose of inclusion in the RHP and the Prospectus (hereinafter collectively referred to as the “Offer Documents”) to be filed with SEBI, BSE Limited (“BSE”), National Stock Exchange of India Limited (“NSE”) and Registrar of Companies, Ahmedabad (“ROC”), in connection with the proposed IPO, is the responsibility of the Management of the Company. The Restated Financial Information have been prepared by the Management of the Company in accordance with the basis of preparation stated in note 2.1 to Annexure V to the Restated Financial Information. The Managements responsibility includes designing, implementing and maintaining internal control relevant to the preparation and presentation of the Restated Financial Information. The Management is also responsible for identifying and ensuring that the Company complies with the Act, SEBI ICDR Regulations and the Guidance Note.

Auditors Responsibilities

4. Our work has been carried out considering the concepts of test checks and materiality to obtain reasonable assurance based on verification of evidence supporting the Restated Financial Information in accordance with the Guidance Note and other applicable authoritative pronouncements issued by the ICAI and pursuant to the requirements of Section 26 of the Act, and the SEBI ICDR Regulations. Our work was performed solely to assist you in meeting your responsibilities in relation to your compliance with the Act, the SEBI ICDR Regulations and the Guidance Note in connection with the Issue.

5. The Guidance Note requires that we comply with the ethical requirements of the Code of Ethics issued by the ICAI.

6. Our examination of the Restated Financial Information has not been carried out in accordance with the auditing standards generally accepted in the United States of America, standards of the Public Company Accounting Oversight Board and accordingly, should not be relied upon by any one as if it had been carried out in accordance with those standards or any other standards besides the standards referred to in this report.

To the Board of Directors of Amanta Healthcare Limited

Report on Restated Financial Information in connection with the Proposed Initial Public Offering Page 3 of 5

7. The Restated Financial Information, expressed in Indian Rupees in lakhs, has been prepared by the Companys Management from: a. the audited financial statements of the Company as at and for the year ended March 31, 2025, prepared in accordance with the Indian Accounting Standards (referred to as “Ind AS”) as prescribed under Section 133 of the Act read with Companies (Indian Accounting Standards) Rules 2015, as amended, and other accounting principles generally accepted in India, which have been approved by the Board of Directors of the Company at their meeting held on July 17, 2025. b. the audited financial statements of the Company as at and for the year ended March 31, 2024, prepared in accordance with the Indian Accounting Standards (referred to as “Ind AS”) as prescribed under Section 133 of the Act read with Companies (Indian Accounting Standards) Rules 2015, as amended, and other accounting principles generally accepted in India, which have been approved by the Board of Directors of the Company at their meeting held on August 24, 2024. The comparative information for the year ended March 31, 2023 included in such financial statements have been prepared by making Ind AS adjustments to the audited financial statements of the Company as at and for the year ended March 31, 2023, prepared in accordance with the accounting standards notified under the section 133 of the Act read with the Companies (Accounting Standards) Rules, 2021 (as amended) which was approved by the Board of Directors at their meeting held on May 11, 2023.

8. For the purpose of our examination, we have relied on a. Auditors report issued by us on the financial statements of the Company as at and for the year ended March 31, 2025 on which we issued an unmodified opinion vide our report dated July 17, 2025 as referred in Paragraph 7 (a) above.

b. Auditors report issued by us on the financial statements of the Company as at and for the year ended March 31, 2024 on which we issued an unmodified opinion vide our report dated August 30, 2024, which also include comparative information prepared by making Ind AS adjustments to the audited financial statements of the Company prepared in accordance with the accounting standards notified under the Section 133 of the Act read with the Companies (Accounting Standards) Rules, 2021 (as amended) as at and for the year ended March 31, 2023 on which we issued an unmodified opinion dated May 11, 2023 as referred in Paragraph 7 (b) above.

9. We have not audited any financial statements of the Company as of any date or for any period subsequent to March 31, 2025. Accordingly, we do not express any opinion on the financial position, results or cash flows of the Company as of any date or for any period subsequent to March 31, 2025.

To the Board of Directors of Amanta Healthcare Limited

Report on Restated Financial Information in connection with the Proposed Initial Public Offering Page 4 of 5

Opinion

10. Based on our examination and according to the information and explanations given to us, we report that the Restated Financial Information: a. have been prepared in accordance with the Act, the SEBI ICDR Regulations and the Guidance Note; b. have been prepared after incorporating adjustments in respect of changes in the accounting policies, material errors and regrouping/reclassifications retrospectively (as disclosed in Annexure VI to the Restated Financial Information) to reflect the same accounting treatment as per the accounting policies as at and for the year ended March 31, 2025, for all the reporting periods; and c. there are no qualifications in the auditors reports requiring any adjustments.

11. The Restated Financial Information do not reflect the effects of events that occurred subsequent to the respective dates of the reports on the audited financial statements mentioned in paragraph 8 above. 12. This report should not in any way be construed as a re-issuance or re-dating of any of the previous audit reports issued by us on any financial statements of the Company. 13. We have no responsibility to update our report for events and circumstances occurring after the date of the report.

Other Matter

14. The auditors report dated August 30, 2024, issued by us on the financial statements of the Company as at and for the year ended March 31, 2024 included the following Other Matter paragraph, which have been reproduced below:

“The financial information of the Company for the year ended March 31, 2023 and the transition date opening balance sheet as at April 1, 2022 included in these Ind AS financial statements, are based on the previously issued statutory financial statements for the years ended March 31, 2023 and March 31, 2022 prepared in accordance with the Companies (Accounting Standards) Rules, 2021 (as amended) which were audited by us, on which we expressed an unmodified opinion dated May 11, 2023 and May 16, 2022, respectively. The adjustments to those financial statements for the differences in accounting principles adopted by the Company on transition to the Ind AS have been audited by us.

Our opinion is not modified in respect of above matter.”

To the Board of Directors of Amanta Healthcare Limited

Report on Restated Financial Information in connection with the Proposed Initial Public Offering Page 5 of 5

Restriction on Use

15. Our obligations in respect of this report are entirely separate from, and our responsibility and liability is in no way changed by, any other role we may have or may have had as the statutory auditor of the Company or otherwise. Nothing in this report, nor anything said or done in the course of or in connection with the services that are the subject of this report, will extend any duty of care we may have or we may have had in our capacity as the statutory auditor of the Company. 16. This report is addressed to and is provided to the Board of Directors of the Company solely for inclusion of the report in the Offer Documents of the Company, to be filed with the SEBI, BSE, NSE and ROC, prepared in connection with the Issue. Our report should not be used by any other person; or be used, circulated, published, quoted, or otherwise be referred to for any other purpose; or be filed with or referred to orally or in any document other than the Offer Documents, in whole or in part. Price Waterhouse Chartered Accountants LLP does not accept or assume any liability or any duty of care for any other purpose or to any person other than the Company.

For Price Waterhouse Chartered Accountants LLP Firm Registration Number: 012754N/N500016

Devang Mehta Partner

Membership Number: 118785 UDIN: 25118785BMLBIJ4366

Place: Mumbai Date: July 17, 2025

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.